András József Szentmiklósi
András József Szentmiklósi
University of Debrecen, Dept Pharmacology and Pharmacotherapy
Verified email at med.unideb.hu
Title
Cited by
Cited by
Year
Red cells, hemoglobin, heme, iron, and atherogenesis
E Nagy, JW Eaton, V Jeney, MP Soares, Z Varga, Z Galajda, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1347-1353, 2010
2022010
Effect of adenosine on sinoatrial and ventricular automaticity of the guinea pig
AJ Szentmiklosi, M Nemeth, J Szegi, JG Papp, L Szekeres
Naunyn-Schmiedeberg's archives of pharmacology 311 (2), 147-149, 1980
921980
Adenosine inhibits the release of interleukin-1β in activated human peripheral mononuclear cells
S Sipka, I Kovács, S Szántó, G Szegedi, L Brugós, G Bruckner, ...
Cytokine 31 (4), 258-263, 2005
452005
Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs
AJ Szentmiklósi, A Ujfalusi, Á Cseppentő, K Nosztray, P Kovacs, JZ Szabó
Naunyn-Schmiedeberg's archives of pharmacology 351 (4), 417-425, 1995
451995
Effects of β‐adrenoceptor stimulation on delayed rectifier K+ currents in canine ventricular cardiomyocytes
G Harmati, T Banyasz, L Barandi, N Szentandrássy, B Horváth, G Szabó, ...
British journal of pharmacology 162 (4), 890-896, 2011
402011
Action potential clamp fingerprints of K+ currents in canine cardiomyocytes: their role in ventricular repolarization
T Bányász, J Magyar, N Szentandrássy, B Horváth, P Birinyi, ...
Acta physiologica 190 (3), 189-198, 2007
382007
Preparation and primary evaluation of [11C] CSC as a possible tracer for mapping adenosine A2A receptors by PET
T Marian, I Boros, Z Lengyel, L Balkay, G Horvath, M Emri, E Sarkadi, ...
Applied radiation and isotopes 50 (5), 887-893, 1999
321999
Novel trends in the treatment of cardiovascular disorders: site-and event-selective adenosinergic drugs
A J Szentmiklosi, A Cseppento, G Harmati, P P Nanasi
Current medicinal chemistry 18 (8), 1164-1187, 2011
312011
Synthesis of 5′‐N‐(2‐[18F]fluoroethyl)‐carboxamidoadenosine: a promising tracer for investigation of adenosine receptor system by PET technique
S Lehel, G Horvath, I Boros, P Mikecz, T Marian, AJ Szentmiklosi, L Tron
Journal of Labelled Compounds and Radiopharmaceuticals: The Official Journal …, 2000
282000
Xanthine derivatives in the heart: Blessed or cursed?
A J Szentmiklosi, A Cseppento, R Gesztelyi, J Zsuga, A Kortvely, ...
Current medicinal chemistry 18 (24), 3695-3706, 2011
202011
The Janus face of adenosine: antiarrhythmic and proarrhythmic actions
A Jozsef Szentmiklosi, Z Galajda, A Cseppento, R Gesztelyi, Z Susán, ...
Current pharmaceutical design 21 (8), 965-976, 2015
192015
On the possible role of adenosine in the hypoxia-induced alterations of the electrical and mechanical activity of the atrial myocardium.
AJ Szentmiklosi, M Nemeth, J Szegi, JG Papp, L Szekeres
Archives Internationales de Pharmacodynamie et de Therapie 238 (2), 283-295, 1979
181979
Concentration estimation via curve fitting: quantification of negative inotropic agents by using a simple mathematical method in guinea pig atria
R Gesztelyi, J Zsuga, B Juhász, P Dér, M Vecsernyés, AJ Szentmiklósi
Bulletin of mathematical biology 66 (5), 1439-1453, 2004
172004
Nitric oxide synthesis is blocked in the enteral nervous system during dormant periods of the snail Helix lucorum
T Röszer, Z Czimmerer, AJ Szentmiklósi, G Bánfalvi
Cell and tissue research 316 (2), 255-262, 2004
172004
Effect of nucleoside transport blockade on the interstitial adenosine level characterized by a novel method in guinea pig atria
D Karsai, J Zsuga, B Juhász, P Dér, AJ Szentmiklósi, Á Tósaki, ...
Journal of cardiovascular pharmacology 47 (1), 103-109, 2006
162006
Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
AJ Szentmiklosi, M Nemeth, A Cseppentö, J Szegi, JG Papp, L Szekeres
Archives internationales de pharmacodynamie et de therapie 256 (2), 236-252, 1982
161982
Chemistry, physiology, and pharmacology of β-adrenergic mechanisms in the heart. Why are β-blocker antiarrhythmics superior?
A Jozsef Szentmiklosi, N Szentandrássy, B Hegyi, B Horváth, J Magyar, ...
Current pharmaceutical design 21 (8), 1030-1041, 2015
152015
The surmountable effect of FSCPX, an irreversible A1 adenosine receptor antagonist, on the negative inotropic action of A1 adenosine receptor full agonists in …
R Gesztelyi, Z Kiss, Z Wachal, B Juhasz, M Bombicz, E Csepanyi, K Pak, ...
Archives of pharmacal research 36 (3), 293-305, 2013
152013
Characterization of nitric oxidergic neurons in the alimentary tract of the snail Helix pomatia L.: histochemical and physiological study
Z Serfözö, AJ Szentmiklósi, K Elekes
Journal of Comparative Neurology 506 (5), 801-821, 2008
142008
Phe-met-arg-phe (FMRF)-amide is a substrate source of NO synthase in the gastropod nervous system
T Rőszer, É Kiss-Tóth, M Petkó, AJ Szentmiklósi, G Bánfalvi
Cell and tissue research 325 (3), 567-575, 2006
142006
The system can't perform the operation now. Try again later.
Articles 1–20